Wire Stories
EuBiologics Gets an IND Approval for Phase I/II Clinical Trial of ‘EuCorVac-19’ in Korea
– Starting the Phase I/II trial in Eunpyeong St. Mary�s Hospital SEOUL, South Korea–(BUSINESS WIRE)–#AntibodyResponse—EuBiologics (KOSDAQ: 206650), a South Korean biotech company,...